Director Sells 45,000 Impinj: Insider Trade Watch Insights
A top executive recently moved a sizable block of Impinj stock. This article unpacks why insider sales happen, how to...
We contrast TRI with price indices, highlighting dividends, corporate actions, and reinvestment assumptions that shape different performance pictures.
24,487 articlesA top executive recently moved a sizable block of Impinj stock. This article unpacks why insider sales happen, how to...
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
Tilray’s stock has been a rollercoaster, but deciding whether to time dump your shares depends on your portfolio, ris...
Three under-$10 energy names are drawing attention as one yields 8.8%, another is up 83% in a year, and market chatte...
When Goldman Sachs raises its dividend as advisory and underwriting fees rebound, investors take notice. This article...
Prediction markets have spoken: a strong probability Nvidia beats earnings. Learn what these odds mean, how reliable ...
CoreWeave's stock has fallen sharply in May as costs rise and guidance disappoints. This guide breaks down the reason...
Investors are weighing Hut 8 and Riot Platforms as data-center developers expanding beyond Bitcoin mining. This guide...
Solana has faced a meaningful pullback in the past three months. This guide breaks down whether solana still worth bu...
Markets are pricing in a Warsh-influenced Fed shift that could widen bank margins. A trio of U.S. banks trading under...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...